Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: New Haven CT, New York NY, Burlington MA, Horsham PA,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: New Haven CT, New York NY, Albany NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase 3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: New Haven CT, New York NY, New Brunswick NJ, Boston MA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase 3, Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: New Haven CT, New York NY, Philadelphia PA, Montreal,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: New Haven CT, New York NY, New Brunswick NJ, Newark DE,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors That Are MTAP Deficient
Location: New Haven CT, Providence RI, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06130553
Phase 1, Phase 2, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: New Haven CT, New York NY, Livingston NJ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase 3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: New Haven CT, Hartford CT, Stony Brook NY,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: New Haven CT, New York NY, Brooklyn NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: New Haven CT, Great Neck NY, Boston MA, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: New Haven CT, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase 3, Recruiting
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
for
Cutaneous Sarcoidosis
Location: New Haven CT, Lake Success NY, New York NY, Brooklyn NY,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06978725
Phase 2, Phase 3, Recruiting
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 8 - 18
Code: NCT00000112
Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
for
Gastrointestinal Stromal Neoplasms
Location: New Haven CT, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07585266
Phase 3, Recruiting
OMAR Opioid Use Disorder
for
Healthy Control, Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05683184
Phase 1, Recruiting
Toward a Computationally-Informed, Personalized Treatment for Hallucinations
for
Hallucinations, Auditory, Psychosis
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT04366518
Early Phase 1, Recruiting
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
for
Alcohol Consumption, Heavy Drinker, Alcohol Use Disorder (AUD)
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 21 - 50
Code: NCT06136195
Phase 1, Recruiting
SV2A in Older Adults
for
Cannabis Use
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 50+
Code: NCT05465538
Phase 1, Phase 2, Recruiting
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning